A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.
about
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkersCurrent and Emerging Uses of Statins in Clinical Therapeutics: A ReviewStatin use and breast cancer survival: a nationwide cohort study from FinlandA clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.Statins and breast cancer prognosis: evidence and opportunities.Effects of statin use on volumetric mammographic density: results from the KARMA study.Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.Preclinical Activity of Simvastatin Induces Cell Cycle Arrest in G1 via Blockade of Cyclin D-Cdk4 Expression in Non-Small Cell Lung Cancer (NSCLC)Statin use and all-cancer survival: prospective results from the Women's Health Initiative.Statins and Breast Cancer: Future Directions in Chemoprevention.The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women.Targeted therapy for breast cancer prevention.Lovastatin lowers the risk of breast cancer: a population-based study using logistic regression with a random effects modelBeyond aspirin-cancer prevention with statins, metformin and bisphosphonates.Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?The Role of Cholesterol in Cancer.Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.7-ketocholesterol and 27-hydroxycholesterol decreased doxorubicin sensitivity in breast cancer cells: estrogenic activity and mTOR pathway.Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer.Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index.Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.
P2860
Q28069856-02010793-E26C-4458-96AA-EC70400BE03EQ28076346-CBF3E85A-37A5-4259-9F89-139C2BBF06B6Q28543933-10C11A0A-4E36-4E87-B894-1CF1ABEE063CQ33901385-FB2C5216-4768-43CA-8D7D-254B48498B6AQ34206487-43E80C2A-9405-4A88-9033-3340A3F92A8EQ35643266-90B7EA40-44E8-4C21-9DEE-E668B1F7AAC9Q36263997-8AF7EDCE-2572-466A-BE6C-406E5F5C4033Q36680139-89354DAD-45D4-4F44-BABE-43BF8DDB9AC1Q36771848-1B5A71A5-B07C-4EBE-8DE1-E30FE087F4B2Q36790259-26438AC0-CB95-4F86-AD5C-A9E9C49C98A8Q37061345-3C32CC28-4CFE-42E8-9126-B40025CD79F1Q37119810-8A852309-9C5D-41CF-81D0-8BD01CB7FB95Q37137519-DCA1D671-BE91-437F-891B-460AA68E3FEDQ37190825-DD5C344D-055D-4ECF-9867-606289DC16B4Q37402139-86FD4CE6-E15B-4D0D-B213-0A2A32121F6BQ38147841-BFFE260A-34ED-4AB3-A2FA-B326BBED75DFQ38802230-08A10191-D026-4FBD-BF72-F42AE36D18C6Q38838555-28CAB1A2-BBB3-4785-A832-EA738F8BE27DQ39455228-32FD9F9D-5B6B-48BF-8587-E33BFE738B14Q42371604-E1C053C3-F5C3-4EA2-93D1-F39791DDC77EQ42561379-67A969E7-85A9-448C-9210-FEE47901051FQ51107564-86B6313B-F310-4612-B29A-835B6E3D9EBFQ51708826-F1023984-D4FE-417F-8B26-EA41435ED263
P2860
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A short-term biomarker modulat ...... d risk of a new breast cancer.
@ast
A short-term biomarker modulat ...... d risk of a new breast cancer.
@en
type
label
A short-term biomarker modulat ...... d risk of a new breast cancer.
@ast
A short-term biomarker modulat ...... d risk of a new breast cancer.
@en
prefLabel
A short-term biomarker modulat ...... d risk of a new breast cancer.
@ast
A short-term biomarker modulat ...... d risk of a new breast cancer.
@en
P2093
P2860
P50
P1476
A short-term biomarker modulat ...... d risk of a new breast cancer.
@en
P2093
Amanda L Blackford
Deborah K Armstrong
Elizabeth Folkerd
Hannah Green
Jacklyn N Thibert
James M Rae
John H Fetting
Judy E Garber
Leisha A Emens
Michaela J Higgins
P2860
P2888
P304
P356
10.1007/S10549-011-1858-7
P407
P577
2011-11-11T00:00:00Z